Deepak Fert & Petro
NSE
₹ 0.00
0.00 (0.00)%
Small-cap
With a market cap of ₹18.90L Cr.
EX-Date | Purpose |
---|---|
28 05 2021 | Dividend & Audited Results Inter alia, the Board will also be considering raising of funds, including but not limited to, public and/or private offerings, qualified institutional placement, American Depository Receipts/Global Depository Receipts, Foreign Currency Convertible Bonds, Fully/partly Convertible Debentures or any fully/partly convertible financial instrument into equity shares or any combination thereof and/ or other permissible securities in one or more tranches |
01 07 2021 | Preferential Issue of shares & Inter- alia, to consider and approve the conversion of Foreign Currency Convertible Bonds (FCCBs) issued to International Finance Corporation (IFC) into equity shares of the Company consequent to exercise of conversion right available to them pursuant to FCCB Subscription Agreement entered between the Company and IFC. |
10 08 2021 | Quarterly Results |
22 10 2021 | inter alia, the Board in its meeting held on 19.10.2021, passed resolutions in connection with the following: (i) raising of funds by way of issue of Equity Shares, through a qualified institutions placement, in accordance with the SEBI ICDR Regulations; (ii) authorizing the opening of the Issue today i.e. on October 19, 2021; (iii) approval of floor price for the Issue being Rs.422.48 per Equity Share, based on the pricing formula as prescribed under Regulation 176 of the SEBI ICDR Regulations; and (iv) approving the preliminary placement document dated October 19, 2021, together with the application form, in connection with the Issue; Further the ?relevant date? for the purpose of the Issue, in terms of Regulation 171(b)(i) of the SEBI ICDR Regulations, is October 19, 2021 and the floor price in respect of the Issue has been determined according to the same, based on the pricing formula as prescribed under Regulation 176(1) of the SEBI ICDR Regulations. The Company may at its discretion offer a discount of not more than 5% on the floor price for the Issue in accordance with the SEBI ICDR Regulations. Further, a meeting of the Securities Issue Committee is scheduled to be held on October 22, 2021 to inter alia consider and approve the issue price, including a discount, if any thereto, and to consider, determine, and approve the date of closing of the Issue, pursuant to the approval of the shareholders of our Company accorded through their resolution passed on August 26, 2021 for the Equity Shares to be allotted to qualified institutional buyers, pursuant to the Issue, as permitted under the SEBI ICDR Regulations. |
12 11 2021 | Quarterly Results |
28 01 2022 | Quarterly Results |
25 05 2022 | Dividend & Audited Results |
29 07 2022 | Quarterly Results |
01 09 2022 | Inter- alia, to consider and approve the conversion of Foreign Currency Convertible Bonds (FCCBs) issued to International Finance Corporation (IFC) (Second Tranche) into equity shares of the Company consequent to exercise of conversion right available to them pursuant to FCCB Subscription Agreement entered between the Company and IFC. |
10 11 2022 | Quarterly Results |
02 02 2023 | Quarterly Results |
17 05 2023 | Audited Results & Dividend |
26 07 2023 | Quarterly Results |
02 11 2023 | Quarterly Results |
01 02 2024 | Quarterly Results |
29 10 2024 | Quarterly Results |
29 01 2025 | Quarterly Results |
No News data available